Newsroom

03-10-2017

Accord Healthcare further reinforces commitment to being the Partner of Choice for Independent Community Pharmacies.

Accord Healthcare are honoured to once again be sponsoring the Pharmacy Team Learning & Development Award at the 2017 Independent Pharmacy Awards.

Read more

15-09-2017

ACCORD HEALTHCARE BOOSTS PORTFOLIO WITH MYCOPHENOLIC ACID GR TABLETS

In line with Accord Healthcare’s vision to be involved in all aspects of bringing pharmaceuticals to patients, it has launched Mycophenolic Acid GR Tablets 180mg and 360mg.

Read more

12-09-2017

LloydsPharmacy to celebrate success of patient safety programme at annual conference

LloydsPharmacy, part of the Celesio UK family, will hold a conference on 6th September dedicated to their patient safety programme, SaferCare. The event will take place at the Holiday Inn,...

Read more

04-08-2017

Procurement team and The Calvert Trust

As you know we have been working with The Calvert Trust which enables people with disabilities, together with their families and friends, to achieve their potential through the challenge of...

Read more

09-01-2017

Intas completes deal

Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses. 

Read more

21-12-2016

Imatinib Accord Launch

Accord Healthcare launches Imatinib Accord 100 mg and 400 mg in the UK.

Accord Healthcare launches Imatinib Accord[1] in the UK, a tyrosine-kinase inhibitor indicated for the treatment...

Read more

05-10-2016

Intas recent acquisition

Intas Pharmaceuticals acquires the generics business of Actavis in the UK & Ireland

Read more

20-01-2016

Aripiprazole Accord Launch

Accord Healthcare is delighted to announce the launch of Aripiprazole Accord, generic version of Abilify®. The product is available in 5, 10, 15 and 30 mg presentations in packs of 28 tablets...

Read more

14-01-2014

Clinigen Group Extends Exclusive Agreement with Accord Healthcare to Supply Anti-Cancer Drug Capecitabine into Clinical Trials in Europe

Burton-on-Trent, UK – 14 January 2014 – Clinigen Group plc (AIM: CLIN) today announced that its Clinical Trials Supply business (Clinigen CTS) has extended its exclusive European Union (EU)...

Read more

Pages